|
|
|
Influenza A (H1N1) (Swine Flu) |
 |
 |
ASM Resources
October 27, 2009
Why is Influenza A Virus Subtyping Important?
October 15, 2009
ASM Guidance on Nasopharyngeal Swab Collection for Influenza (including novel H1N1)
October 5, 2009
ASM’s Interim Algorithm for Guidance in Testing of Patients with Respiratory Illness for Influenza A (including Novel H1N1)
WHO Advisories
Update: On June 11, 2009 the World Health
Organization (WHO) raised the threat level on Influenza A (H1N1) to Phase 6. At
this time, WHO considers the overall severity of the influenza pandemic to be
moderate. This assessment is based on scientific evidence available to WHO, as
well as input from its Member States on the pandemic's impact on their health
systems, and their social and economic functioning. June 11,
2009WHO:
Updated H1N1 Frequently Asked Questions:
What is Phase 6?WHO
Pandemic Phase DescriptionsWHO
Guidance Document: Pandemic Influenza Preparedness and Response
May 1, 2009The CDC, a WHO Collaborating Centre for Influenza is providing information and documents on its diagnostic protocols for detection and characterization of Swine Influenza, including: CDC Realtime RTPCR (rRTPCR) Protocol for Detection and Characterization of Swine InfluenzaProtocol for Antiviral Susceptibility Testing by PyroSequencingCDC Real-time RTPCR Swine H1 Assay ordering InstructionsApril 30, 2009Joint FAO/WHO/OIE Statement on influenza A(H1N1) and the safety of pork April 29, 2009 WHO Issues Instructions for Shipments of Swine Influenza A (H1N1) Specimens and Virus Isolates to WHO Collaborating Centres for Influenza CDC Advisories and Alerts
December 7, 2009
Updated
Interim Recommendations for the Use of Antiviral Medications in the Treatment
and Prevention of Influenza for the 2009-2010 Season
November 6, 2009
Quick Facts for Clinicians on Antiviral
Treatments for 2009 H1N1
October 14,
2009
Interim Guidance
on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings,
Including Protection of Healthcare Personnel Questions and
Answers about CDC’s Interim Guidance on Infection Control Measures for 2009 H1N1
Influenza in Healthcare Settings, Including Protection of Healthcare
Personnel Questions and
Answers Regarding Respiratory Protection For Preventing 2009 H1N1 Influenza
Among Healthcare Personnel
October 9,
2009
Interim Guidance
for Influenza Surveillance: Prioritizing RT-PCR Testing in
Laboratories September 29, 2009
Interim Recommendations for Clinical
Use of Influenza Diagnostic Tests During the 2009-10 Influenza
Season2009 H1N1 Influenza Vaccine –
Q&ASeptember
23, 2009
Questions &
Answers: Antiviral Drugs, 2009-2010 Flu Season
September 3, 2009
MMWR: Surveillance for
Pediatric Deaths associated with 2009 Pandemic Influenza A (H1N1) Virus
Infection, United
States, April-August, 2009Interim Guidance for Reporting Influenza-Associated Hospitalizations and Deaths for the 2009-2010 Season
August 28,
2009
MMWR: 2009 Pandemic Influenza A (H1N1) Virus
Infections, Chicago,
Illinois, April - July 2009
MMWR: Surveillance for the 2009 Pandemic
Influenza A (H1N1) Virus and Seasonal Influenza Viruses, New Zealand,
2009
August 21,
2009
MMWR: Use of Influenza A (H1N1) 2009 Monovalent
Vaccine, Recommendations of the Advisory Committee on Immunization Practices
(ACIP), 2009.
August 14,
2009
MMRW:
Oseltamivir-Resistant
Novel Influenza A (H1N1) Virus Infection in Immunosuppressed Patients Receiving
Oseltamivir Therapy
August 10, 2009
Interim
Guidance for the Detection of Novel Influenza A Virus Using Rapid Influenza
Diagnostic Tests
August 6, 2009
MMWR-Evaluation of Rapid Influenza Diagnostic Tests for Detection of Novel Influenza A (H1N1) Virus --- United States, 2009June 4, 2009Q&As Abount CDC's Online Reporting
June 1, 2009
Updated Interim Guidance on Case Definitions to be Used For Investigations of Novel Influenza A (H1N1) Cases
May 28, 2009Post-mortem Care and Safe Autopsy Procedures for Novel H1N1 Influenza
May 27, 2009 This revised document includes guidance on facemask and respirator use for a wider range of settings than was included in previous documents and includes recommendations for those who are at increased risk of severe illness from infection with the novel H1N1 virus compared with those who are at lower risk of severe illness from influenza infection.
May 26, 2009CDC: DSAT Guidance on CDC Import Permits for Swine-Originated Flu
A CDC Import Permit is required for the importation into the United States of virus isolates and/or clinical samples associated with the swine-origin, novel influenza A (H1N1) virus outbreak. A CDC Import Permit is not required for the (1) transfer of those virus isolates and/or clinical samples associated with the swine-origin, novel influenza A (H1N1) virus outbreak, which originate in the United States; or (2) the further distribution of virus isolates and/or clinical samples associated with the swine-origin, novel influenza A (H1N1) virus outbreak that originally had been imported into the United States under CDC permit.
May 23, 2009
May 13, 2009 |
|
Last Updated on Tuesday, 15 December 2009 14:58 |
|
|
